Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Expert Practical Recommendations for Hepatocellular Carcinoma100
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype38
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma35
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD35
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns29
Genetic and Epigenetic Basis of Drug-Induced Liver Injury26
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease26
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease23
HBV Biomarkers and Their Role in Guiding Treatment Decisions23
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis22
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies19
Physiomimetic In Vitro Human Models for Viral Infection in the Liver18
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury18
Wilson Disease: Novel Diagnostic and Therapeutic Approaches17
Diagnosis and Management of Early Stages of ALD16
Mice Engrafted with Human Liver Cells16
0.16217613220215